α1-Antitrypsin phenotypes and associated serum protein concentrations in a large clinical population

α1-Antitrypsin (AAT) deficiency variants reduce the concentration of serum AAT protease inhibitor and can lead to the development of pulmonary and hepatic disease. Relative frequencies of rare AAT variant phenotypes (non-M, Z, and S) and associated serum concentrations in the clinical population hav...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Chest Jg. 143; H. 4; S. 1000
Hauptverfasser:	Bornhorst, Joshua A, Greene, Dina N, Ashwood, Edward R, Grenache, David G
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States 01.04.2013
Schlagworte:	Adolescent Adult Aged Aged, 80 and over Algorithms alpha 1-Antitrypsin - blood alpha 1-Antitrypsin - classification alpha 1-Antitrypsin Deficiency - blood alpha 1-Antitrypsin Deficiency - diagnosis Biomarkers - blood Child Child, Preschool Female Humans Infant Isoelectric Focusing - methods Male Middle Aged Phenotype Retrospective Studies Sensitivity and Specificity Young Adult
ISSN:	1931-3543, 1931-3543
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Abstract	α1-Antitrypsin (AAT) deficiency variants reduce the concentration of serum AAT protease inhibitor and can lead to the development of pulmonary and hepatic disease. Relative frequencies of rare AAT variant phenotypes (non-M, Z, and S) and associated serum concentrations in the clinical population have not been thoroughly described. Protein phenotypes were determined by isoelectric focusing electrophoresis for 72,229 consecutive samples. Phenotype frequencies, median serum concentrations, and central 95% concentration intervals were determined for observed phenotypes. Concurrent AAT phenotype and concentration data were used to evaluate the efficacy of using serum AAT concentration alone to detect AAT deficiency. Age, race, and sex had only slight effects on the median 95% serum protein concentration intervals of the 58,087 PiMM (wild type) phenotype specimens. Positive predictive values were calculated for the detection of potential deficiency phenotypes at different serum cutoff concentrations, aiding potential screening effort design. For example, the PiZZ deficiency phenotype (n = 814) could be detected at 99.5% sensitivity and 96.5% specificity using a cutoff of ≤ 85 mg/dL. However, at-risk specimens with two putative deleterious variants (Z, S, I, F, P, T, and Null variants) were detected with only 85.9% sensitivity at this cutoff (n = 1,661). Rare phenotype variants were observed in 2.5% of samples. This analysis provides novel information on serum AAT concentrations associated with different AAT phenotypes and provides insight into the severity of depression of AAT concentration in the presence of rare deficiency variants. Additionally, it allows for evaluation of efficacy of testing algorithms incorporating AAT serum concentration determination.
AbstractList	α1-Antitrypsin (AAT) deficiency variants reduce the concentration of serum AAT protease inhibitor and can lead to the development of pulmonary and hepatic disease. Relative frequencies of rare AAT variant phenotypes (non-M, Z, and S) and associated serum concentrations in the clinical population have not been thoroughly described.BACKGROUNDα1-Antitrypsin (AAT) deficiency variants reduce the concentration of serum AAT protease inhibitor and can lead to the development of pulmonary and hepatic disease. Relative frequencies of rare AAT variant phenotypes (non-M, Z, and S) and associated serum concentrations in the clinical population have not been thoroughly described.Protein phenotypes were determined by isoelectric focusing electrophoresis for 72,229 consecutive samples. Phenotype frequencies, median serum concentrations, and central 95% concentration intervals were determined for observed phenotypes. Concurrent AAT phenotype and concentration data were used to evaluate the efficacy of using serum AAT concentration alone to detect AAT deficiency.METHODSProtein phenotypes were determined by isoelectric focusing electrophoresis for 72,229 consecutive samples. Phenotype frequencies, median serum concentrations, and central 95% concentration intervals were determined for observed phenotypes. Concurrent AAT phenotype and concentration data were used to evaluate the efficacy of using serum AAT concentration alone to detect AAT deficiency.Age, race, and sex had only slight effects on the median 95% serum protein concentration intervals of the 58,087 PiMM (wild type) phenotype specimens. Positive predictive values were calculated for the detection of potential deficiency phenotypes at different serum cutoff concentrations, aiding potential screening effort design. For example, the PiZZ deficiency phenotype (n = 814) could be detected at 99.5% sensitivity and 96.5% specificity using a cutoff of ≤ 85 mg/dL. However, at-risk specimens with two putative deleterious variants (Z, S, I, F, P, T, and Null variants) were detected with only 85.9% sensitivity at this cutoff (n = 1,661). Rare phenotype variants were observed in 2.5% of samples.RESULTSAge, race, and sex had only slight effects on the median 95% serum protein concentration intervals of the 58,087 PiMM (wild type) phenotype specimens. Positive predictive values were calculated for the detection of potential deficiency phenotypes at different serum cutoff concentrations, aiding potential screening effort design. For example, the PiZZ deficiency phenotype (n = 814) could be detected at 99.5% sensitivity and 96.5% specificity using a cutoff of ≤ 85 mg/dL. However, at-risk specimens with two putative deleterious variants (Z, S, I, F, P, T, and Null variants) were detected with only 85.9% sensitivity at this cutoff (n = 1,661). Rare phenotype variants were observed in 2.5% of samples.This analysis provides novel information on serum AAT concentrations associated with different AAT phenotypes and provides insight into the severity of depression of AAT concentration in the presence of rare deficiency variants. Additionally, it allows for evaluation of efficacy of testing algorithms incorporating AAT serum concentration determination.CONCLUSIONSThis analysis provides novel information on serum AAT concentrations associated with different AAT phenotypes and provides insight into the severity of depression of AAT concentration in the presence of rare deficiency variants. Additionally, it allows for evaluation of efficacy of testing algorithms incorporating AAT serum concentration determination. α1-Antitrypsin (AAT) deficiency variants reduce the concentration of serum AAT protease inhibitor and can lead to the development of pulmonary and hepatic disease. Relative frequencies of rare AAT variant phenotypes (non-M, Z, and S) and associated serum concentrations in the clinical population have not been thoroughly described. Protein phenotypes were determined by isoelectric focusing electrophoresis for 72,229 consecutive samples. Phenotype frequencies, median serum concentrations, and central 95% concentration intervals were determined for observed phenotypes. Concurrent AAT phenotype and concentration data were used to evaluate the efficacy of using serum AAT concentration alone to detect AAT deficiency. Age, race, and sex had only slight effects on the median 95% serum protein concentration intervals of the 58,087 PiMM (wild type) phenotype specimens. Positive predictive values were calculated for the detection of potential deficiency phenotypes at different serum cutoff concentrations, aiding potential screening effort design. For example, the PiZZ deficiency phenotype (n = 814) could be detected at 99.5% sensitivity and 96.5% specificity using a cutoff of ≤ 85 mg/dL. However, at-risk specimens with two putative deleterious variants (Z, S, I, F, P, T, and Null variants) were detected with only 85.9% sensitivity at this cutoff (n = 1,661). Rare phenotype variants were observed in 2.5% of samples. This analysis provides novel information on serum AAT concentrations associated with different AAT phenotypes and provides insight into the severity of depression of AAT concentration in the presence of rare deficiency variants. Additionally, it allows for evaluation of efficacy of testing algorithms incorporating AAT serum concentration determination.
Author	Bornhorst, Joshua A Grenache, David G Greene, Dina N Ashwood, Edward R
Author_xml	– sequence: 1 givenname: Joshua A surname: Bornhorst fullname: Bornhorst, Joshua A email: jabornhorst@uams.edu organization: Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR. Electronic address: jabornhorst@uams.edu – sequence: 2 givenname: Dina N surname: Greene fullname: Greene, Dina N organization: The Permanente Medical Group Regional Laboratories, Kaiser Permanente Northern California, Berkeley, CA – sequence: 3 givenname: Edward R surname: Ashwood fullname: Ashwood, Edward R organization: Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT; ARUP Laboratories Institute of Clinical and Experimental Pathology, Salt Lake City, UT – sequence: 4 givenname: David G surname: Grenache fullname: Grenache, David G organization: Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT; ARUP Laboratories Institute of Clinical and Experimental Pathology, Salt Lake City, UT
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/23632999$$D View this record in MEDLINE/PubMed
BookMark	eNpNkMtOwzAQRS1URB-wZIu8ZJPiVx5eVhUFpEpsYB059pgaJXaInUU_ix_hm4igSKzu3DtHo9FdopkPHhC6pmRNeVnd6QPEtKYsI3khztCCSk4zngs--zfP0TLGd0IIpbK4QHPGC86klAsEX5802_jk0nDso_O4P4AP6dhDxMobrGIM2qkEBkcYxg73Q0gwcTp4DT4NKrngI54ShVs1vAHWrfNOqxb3oR_bn_0lOreqjXB10hV63d2_bB-z_fPD03azz7RgPGUgiZCWUSvLiti8IUYwA8rohuWUKysn01DGDNUEWC6FLi3YsjAVA2VpxVbo9vfu9OXHOBVTdy5qaFvlIYyxplyUZSUrQib05oSOTQem7gfXqeFY_1XDvgE8SWs_
CitedBy_id	crossref_primary_10_1136_bcr_2017_222036 crossref_primary_10_1016_j_clinbiochem_2017_09_010 crossref_primary_10_1016_j_arbr_2013_10_010 crossref_primary_10_1186_s40246_023_00497_1 crossref_primary_10_1007_s00431_023_04825_4 crossref_primary_10_1183_13993003_02410_2019 crossref_primary_10_1378_chest_13_1464 crossref_primary_10_1007_s15036_018_0452_9 crossref_primary_10_1186_s12931_023_02553_9 crossref_primary_10_1186_s12931_015_0256_9 crossref_primary_10_1111_all_13558 crossref_primary_10_1097_TP_0000000000003390 crossref_primary_10_2147_COPD_S327803 crossref_primary_10_1177_1753465815602162 crossref_primary_10_1186_s12931_018_0826_8 crossref_primary_10_1016_j_clinbiochem_2020_05_001 crossref_primary_10_1515_cclm_2022_0967 crossref_primary_10_1111_jocs_14256 crossref_primary_10_1186_s12890_021_01466_x crossref_primary_10_1182_blood_2017_11_815746 crossref_primary_10_1097_MPG_0000000000001716 crossref_primary_10_1002_lt_25652 crossref_primary_10_1586_ers_13_20 crossref_primary_10_1097_HC9_0000000000000023 crossref_primary_10_1016_j_jsbmb_2019_01_014 crossref_primary_10_1111_joim_12239 crossref_primary_10_1002_lt_25057 crossref_primary_10_1183_13993003_02628_2020 crossref_primary_10_1183_23120541_00583_2021 crossref_primary_10_1183_13993003_00713_2020 crossref_primary_10_2147_TACG_S257511 crossref_primary_10_1097_PAI_0000000000000101 crossref_primary_10_1080_17476348_2016_1249851 crossref_primary_10_1016_j_ccm_2016_04_011 crossref_primary_10_1515_cclm_2020_0071 crossref_primary_10_1016_j_jmoldx_2015_07_002 crossref_primary_10_1016_j_chpulm_2024_100076 crossref_primary_10_1309_AJCPR7EIQS8PIMLV crossref_primary_10_1111_ijd_12902 crossref_primary_10_1016_j_omtm_2022_04_003 crossref_primary_10_1378_chest_13_1974 crossref_primary_10_1186_s13023_024_03069_1 crossref_primary_10_1089_respcare_12524 crossref_primary_10_1093_ajcp_aqw112 crossref_primary_10_1080_00325481_2017_1381539 crossref_primary_10_1016_j_arbres_2013_05_004 crossref_primary_10_1373_jalm_2017_025858 crossref_primary_10_1155_2020_4019608 crossref_primary_10_1513_AnnalsATS_201506_344KV crossref_primary_10_1186_1479_7364_7_22
ContentType	Journal Article
DBID	CGR CUY CVF ECM EIF NPM 7X8
DOI	10.1378/chest.12-0564
DatabaseName	Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic
DatabaseTitle	MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic
DatabaseTitleList	MEDLINE - Academic MEDLINE
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	no_fulltext_linktorsrc
Discipline	Medicine
EISSN	1931-3543
ExternalDocumentID	23632999
Genre	Evaluation Studies Research Support, Non-U.S. Gov't Journal Article
GroupedDBID	--- .1- .55 .FO .GJ .XZ 08P 0R~ 18M 1P~ 29B 2WC 354 36B 3O- 457 53G 5GY 5RE 5RS 6J9 6PF 7RV 7X7 88E 8AO 8C1 8F7 8FI 8FJ AAEDT AAEDW AAKAS AAKUH AALRI AAWTL AAXUO AAYOK ABDBF ABDQB ABJNI ABLJU ABMAC ABOCM ABUWG ACBMB ACGFO ACGFS ACGUR ACUHS ADBBV ADVLN ADZCM AENEX AEVXI AFCTW AFETI AFFNX AFJKZ AFKRA AFRHN AFTJW AGHFR AHMBA AI. AITUG AJUYK AKRWK ALIPV ALMA_UNASSIGNED_HOLDINGS AMRAJ AZQEC B0M BCGUY BENPR BKEYQ BKNYI BPHCQ BVXVI C1A C45 CCPQU CGR CS3 CUY CVF DU5 EAP EAS EBC EBD EBS ECM EHN EIF EJD EMK ENC EPT ESX EX3 F5P FDB FYUFA GD~ H13 HMCUK HX~ HZ~ IH2 INR J5H K9- L7B LXL LXN M0R M1P M5~ MJL MV1 N4W N9A NAPCQ NEJ NPM O6. O9- OB3 OBH ODZKP OFXIZ OGROG OHH OI- OU. OVD OVIDX P2P PCD PHGZT PQQKQ PROAC PSQYO Q~Q RIG ROL SJN SSZ TCP TEORI TR2 TUS TWZ UKHRP VH1 W8F WH7 WOQ WOW X7M XOL YFH YHG YOC YQJ Z5R ZGI ZRQ ZXP ZY1 ~8M 7X8 ACVFH ADCNI ADGHP EFKBS
ID	FETCH-LOGICAL-c423t-e9049f21f9780f5b0d42deadcb2513af9deab122d1c0e2594c7fef76d82eaf182
IEDL.DBID	7X8
ISSN	1931-3543
IngestDate	Sat Sep 27 20:58:36 EDT 2025 Thu Apr 03 07:09:40 EDT 2025
IsPeerReviewed	true
IsScholarly	true
Issue	4
Language	English
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c423t-e9049f21f9780f5b0d42deadcb2513af9deab122d1c0e2594c7fef76d82eaf182
Notes	ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Undefined-1 ObjectType-Feature-3 content type line 23
PMID	23632999
PQID	1347789800
PQPubID	23479
ParticipantIDs	proquest_miscellaneous_1347789800 pubmed_primary_23632999
PublicationCentury	2000
PublicationDate	2013-Apr
PublicationDateYYYYMMDD	2013-04-01
PublicationDate_xml	– month: 04 year: 2013 text: 2013-Apr
PublicationDecade	2010
PublicationPlace	United States
PublicationPlace_xml	– name: United States
PublicationTitle	Chest
PublicationTitleAlternate	Chest
PublicationYear	2013
References	24189872 - Chest. 2013 Nov;144(5):1732-3 24189873 - Chest. 2013 Nov;144(5):1733-4
References_xml	– reference: 24189873 - Chest. 2013 Nov;144(5):1733-4 – reference: 24189872 - Chest. 2013 Nov;144(5):1732-3
SSID	ssj0001196
Score	2.354465
Snippet	α1-Antitrypsin (AAT) deficiency variants reduce the concentration of serum AAT protease inhibitor and can lead to the development of pulmonary and hepatic...
SourceID	proquest pubmed
SourceType	Aggregation Database Index Database
StartPage	1000
SubjectTerms	Adolescent Adult Aged Aged, 80 and over Algorithms alpha 1-Antitrypsin - blood alpha 1-Antitrypsin - classification alpha 1-Antitrypsin Deficiency - blood alpha 1-Antitrypsin Deficiency - diagnosis Biomarkers - blood Child Child, Preschool Female Humans Infant Isoelectric Focusing - methods Male Middle Aged Phenotype Retrospective Studies Sensitivity and Specificity Young Adult
Title	α1-Antitrypsin phenotypes and associated serum protein concentrations in a large clinical population
URI	https://www.ncbi.nlm.nih.gov/pubmed/23632999 https://www.proquest.com/docview/1347789800
Volume	143
hasFullText
inHoldings	1
isFullTextHit
isPrint
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LSwMxEA5qRbz4ftQXEbzGdrOPJCcpYvFgSw8qvS3ZbAIF3a7dVvBn-Uf8Tc5sU3sSBC8Lu2SXJZlJvmRmvo-QqyCLYBE2hkXOChaBTzCJfpVIqWOXgEPVyePPD6Lfl8OhGvgDt8qnVS7mxHqizscGz8hbWPIopAJ8c1O-MVSNwuiql9BYJY0QoAw6phgu2cKDoNbnAowSsDCOQs-xGQrZqtWorjEtIUaygd_QZb3KdLf_-387ZMvjS9qZG8QuWbHFHtno-Qj6PrFfnwHrYG3u5KOsRgXFHK8xHsRWVBc51X64bE7BOGevtCZygHYG6xsLT7JbUXii6QumkdNFcSUtf8TADshT9-7x9p55qQVmAE9NmVWwU3A8cEhI5OKsnUc8ByMzGeCfUDsFN1nAeR6YtoUdU2SEs04kueRWO9ijHJK1YlzYY0KFgSHmSZY75K4PuTIyUdxIy61TOlFNcrnowBRMGeMTurDjWZUuu7BJjuajkJZzzo2Uh_gppU7-8PYp2eS1aAXm15yRhgNHtudk3bxPR9XkorYRuPYHvW_hu8ot
linkProvider	ProQuest
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%CE%B11-Antitrypsin+phenotypes+and+associated+serum+protein+concentrations+in+a+large+clinical+population&rft.jtitle=Chest&rft.au=Bornhorst%2C+Joshua+A&rft.au=Greene%2C+Dina+N&rft.au=Ashwood%2C+Edward+R&rft.au=Grenache%2C+David+G&rft.date=2013-04-01&rft.issn=1931-3543&rft.eissn=1931-3543&rft.volume=143&rft.issue=4&rft.spage=1000&rft_id=info:doi/10.1378%2Fchest.12-0564&rft.externalDBID=NO_FULL_TEXT
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1931-3543&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1931-3543&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1931-3543&client=summon